Li Qiaofang,Li Shuguang,Xu Jinrui,Deng Wenzhao,Song Chunyang,Wang Xuan,Zhu Shuchai.Survival analysis of patients with non-surgical esophageal carcinoma receiving intensity-modulated radiotherapy (IMRT) alone[J].Chinese Journal of Radiological Medicine and Protection,2020,40(8):600-605
Survival analysis of patients with non-surgical esophageal carcinoma receiving intensity-modulated radiotherapy (IMRT) alone
Received:October 09, 2019  
DOI:10.3760/cma.j.issn.0254-5098.2020.08.005
KeyWords:Esophageal carcinoma  Elective nodal irradiation (ENI)  Involved-field irradiation (IFI)  Intensity-modulated radiotherapy  Prognostic factors
FundProject:
Author NameAffiliationE-mail
Li Qiaofang Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China  
Li Shuguang Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China  
Xu Jinrui Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China  
Deng Wenzhao Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China  
Song Chunyang Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China  
Wang Xuan Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China  
Zhu Shuchai Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China sczhu1965@163.com 
Hits: 2465
Download times: 1117
Abstract::
      Objective To evaluate the efficacy of target area of radical radiotherapy for inoperable esophageal carcinoma patients treated with intensity-modulated radiotherapy (IMRT). Methods A retrospective analysis was performed on the clinical data of 564 Ⅰ-Ⅳ non-surgical esophageal cancer who received definitive intensity-modulated radiotherapy alone in our hospital from 2006 to 2015. Propensity score matching (PSM) was used to identify well-balanced patients for comparison. The Kaplan-Meier method was used to calculate local-regional failure-free survival (LRFFS), progression-free survival (PFS), overall survival (OS) rates and univariate analysis. The multivariate analysis of prognostic factors were tested by COX proportional hazard model. Results The last follow-up time was December 2018, the median follow-up time was 99.7 (95% CI:77.5-122.1) months. Follow-up rate was 95.9%. For the 564 patients, the 1-, 3-, 5-year LRFFS were 61.5%, 26.5%, 14.3%, PFS were 56.7%, 25.0%, 13.4%, OS were 73.0%, 31.1%, 16.8%. After PSM, for the elective-nodal irradiation (ENI) (n=141) and involved-nodal irradiation (IFI) (n=141) groups, the 1-, 3-, 5-year LRFFS were 68.8%, 34.2%, 19.1% vs. 65.2%, 32.1%, 17.9% (P>0.05), PFS were 63.1%, 31.0%, 16.6% vs. 60.3%, 29.3%, 16.6% (P>0.05), OS were 80.9%, 41.5%, 23.3% vs. 80.1%, 35.0%, 20.2% (P>0.05). In multivariate analysis, tumor volume ≤ 37 cm3 and Ⅰ+Ⅱ stage were independent factors for LRFFS, PFS and OS. Subgroup analysis showed that there were no significant differences in the survival rates between the ENI group and IFI group (P>0.05). Comparing to the IFI group, ENI reduced the local-regional failure rate (P=0.048). Conclusions Using intensity-modulated radiation therapy alone for inoperable esophageal carcinoma, ENI can significantly reduce the local-regional failure rate, but not improve survival rates compared to the IFI.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9069366  On-line:0

v
Scan QR Code
&et=33954BD322E648EDC338F04C00A86BD6105D5A225F4F9B985C590AD96656E253F1E00B4DBA77B3793F2B7E58B74F8D520BA371E7CAB5E4E00C91F323DB1A1A06C70346A46B7BE9CB9E7F140EE646641C5582D1EC7D6BFB164898FA07B1968153A09FDD3591C126230D64066ED776CEA2C301B91050A679CC9A9144D892D4946C&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=0D1D160AB8016934&aid=47415C07092E978C9905E3125178C265&vid=&iid=5D311CA918CA9A03&sid=1D5555D0B4345CA8&eid=10A39635766FF5D0&fileno=20200805&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="0D1D160AB8016934"; var my_aid="47415C07092E978C9905E3125178C265";